90142 (612782), страница 5
Текст из файла (страница 5)
35. Paradisio P. Combined childhood immunizations [Letter]. JAMA 1992; 268: 1685.
36. Paradiso P, Hogerman D, Madore D, et al. Safety and immunogenicity in infants of a tetravalent vaccine composed of HbOC (HibTITER) and DTP (TRI-IMMUNOL) [Abstract 1028]. Pediatr Res 1992;31:174A.
37. Prikazsky V, Wynen J, Vandepapeliere P. A combined diphtheria, tetanus and hepatitis B vaccine to facilitate integration of hepatitis B vaccine into EPI. Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 17 to 20, 1993.
38. Peltola H, Eskola J, Kayhty H, et al. Clinical efficacy of the PRP-D vs. HbOC conjugate vaccines against Haemophilus influenzae type b (Hib). In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11 to 14, 1992.
39. Qureshi AW, Zulfiqar I, Siddiqui RN. Comparison of immunogenicity of combined DTP inactivated injectable polio vaccine (DPT-IPV) and association of DPT and attenuated oral polio vaccine (DPT+OPV) in Pakistani children. J Pakistan Med Assoc 1989; 39:31-5.
40. Rennels MB, Reed GF, Edwards KM, et al. Comparison of reactogenicity of acellular and whole cell DTP vaccines given alone or simultaneously with Haemophilus influenzae type b conjugate vaccine [Abstract 585]. Pediatr Res 1992; 31: 100A.
41. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991; 324: 1767 - 72.
42. Scheifele D, Bjornson G, Barreto L, Meekison W, Guasparini R. Controlled trial of Haemophilus influenzae type b diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection. Vaccine 1992;10: 455 - 60.
43. Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Can Haemophilus influenzae type-b tetanus toxoid conjugate vaccine be combined with diphtheria toxoid, pertussis vaccine, tetanus toxoid? Can Med Assoc J 1993; 149:1105-11.
44. Shinefield H, Black S, Adelman T, Ensor K, Hogerman D. Safety and immunogenicity of DTaP-HbOC-combined oligosaccharide conjugate (HbOC, HibTITER) Haemophilus influenzae type b and acellular DTP vaccine (DTaP) in toddlers. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11 to 14, 1992.
45. Steinhoff MC, Thomas ML, Dannenfelser S, O'Donovan C. Immunogenicity of H. influenzae type b-CRM197 conjugate vaccine (HbOC) given simultaneously with routine childhood immunizations. Pediatr Res 1990; 27:184A.
46. Ward J, Brenneman G, Letson GW, Heyward WL, the Alaska H. influenzae Vaccine Study Group. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. N Encl J Med 1990; 323 :1393 - 401.
47. Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis 1991; 10:758 -- 61.
48. Berger R, Just M. Lack of interference between vaccines [Letter]. Pediatr Infect Dis 1983; 2:172.
49. Deforest A, Long SS, Lischner HW, et al. Simultaneous administration of measles-mumps-rubella vaccine with booster dose of diphtheria-tetanus-pertussis and poliovirus vaccines. Pediatrics 1998; 81:237-46.
50. Huang LM, Lee CY, Hsu CY, et al. Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine. Pediatr Infect Dis J 1990;9:461 -- 5.
51. John TJ. Selvakumar R, Balrai V, Simoes EAF. Antibody response to measles vaccine with DTPP [Letter]. Am J Dis Child 1987; 141:14.
52. Krugman RD, Witte JJ, Parkman PD, et al. Combined administration of measles, mumps, rubella and trivalent oral poliovirus vaccines. Public Health Rep 1977; 92:220-2.
53. Rothstein E, Bernstein H, Pennridge Pediatric Association, et al. Simultaneous administration of an acellular pertussis-DT vaccine (APDT) with MMR and OPV vaccines. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11 to 14, 1992.
54. Simoes EAF, Balraj V, Selvakumar R, John TJ. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine. Am J Dis Child 1988; 142:309-11.
55. Parkman PD, Hopps HE, Albrecht P, Meyer HM Jr. Simultaneous administration of vaccines: recent advances in immunization. PAHO scientific publication 451. Washington, DC: Pan American Health Organization, 1983.
56. Halsey N, Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull WHO 1985; 63:1151-69.
57. Edwards KM, Decker MD, Halsey NA. et al. Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 1991; 88 : 1019-23.
58. Halperin SA, Bortolussi R, MacLean D, Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia enhanced pertussis surveillance program. J Pediatr 1989; 115:686-93.
59. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650 -- 60.
60. Long SS, Deforest A, Pennridge Pediatric Associates, Smith DG, Lazaro C, Wassilak SGF. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics 1990; 85:294-302.
61. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double blind placebo-controlled trial in twins. Lancet 1986: 2:939-42.
62. Centers for Disease Control and Prevention. Adverse events following Immunization Surveillance Report No. 3, 1985 -- 86, Issued February 1989.
63. Centers for Disease Control and Prevention. New recommended schedule for' active immunization of normal infants and children. MMWR 1986; 35:577-9.
64. Black SB, Shinefield HR. Fireman B, et al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 O8O children. Pediatr Infect Dis J 1991; 10:97-104.
65. Peltola H, Eskola J, Kayhty, et al. Clinical efficacy of the PRP-D vs. HbOC conjugate vaccines against Haemophilus influenzae type b (Hib). In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11 to 14, 1992.
66. Booy R, Aitken SJM, Taylor S, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months versus 3, 5, and 9 months of age. Lancet 1992; 339:507-10.
67. Booy R, Moxon ER, MacFarlane JA, Mayon-White RT, Slack MPE. Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region [Letter]. Lancet 1992; 340:847.
68. Rennels MB, Edwards KM, Anderson EL, et al. Effect on pertussis immune responses of administering Haemophilus influenzae type b (HIB) at the same time as acellular or whole cell DTP vaccine. Pediatr Res 1992; 31:100A. Abstract 584.
1 Принято для опубликования 22 февраля 1994г.
Национальная программа иммунизации, Центры по борьбе с болезнями и их профилактике, г.Атланта, шт.Джорджия.
Ключевые слова: детские прививки, неблагоприятные события, иммуногенность, одновременное введение.
Адрес для перепечаток: Gail King, M.D., M.P.H., National Immunization Program, Centers for Disease Control, 1600 Clifton Rd. N.E., MS-E61, Atlanta, GA 30333.
1
2
3
4
6
7
9
1
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
